Optimize PPI dose, timing, and drug<sup>18</sup>

By rray, 23 December, 2014
Exclude Patient Type Detail Header
No
Footnote
<sup>18</sup> Traditional delayed-release PPIs should be administered 30-60 min ac for max pH control [S/M]; newer PPIs may offer dosing flexibility relative to mealtime [C/M]. Optimize PPI: increase PPI dosing to bid or consider a switch to a different PPI [C/L]. If nocturnal sx, sleep disturbance, and/or variable schedules: consider dose-timing adjustment and/or bid dosing [S/L]. Bedtime H2RA tx can be added prn to daytime PPI tx in pts w/ nighttime sx, but tachyphylaxis may occur after several wks of use [C/L]. If PPI side-effects: switch PPIs [C/L]. PPI switching is common in practice; there are limited data to support this; no data to support switching PPIs ≥1x in partial/nonresponders. Meta-analyses fail to show significant efficacy difference for sx relief between PPIs. <br><br><sup>19</sup> Traditional delayed-release PPIs should be administered 30-60 min ac for max pH control [S/M]; newer PPIs may offer dosing flexibility relative to mealtime [C/M]. <br><br>
<sup>20</sup> PPI switching is common in practice; there are limited data to support this; no data to support switching PPIs ≥1x in partial/nonresponders. Meta-analyses fail to show significant efficacy difference for sx relief between PPIs.
Detail Type
Text